Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

47.59
+0.28000.59%
Pre-market: 47.960.3700+0.78%06:03 EST
Volume:2.49M
Turnover:118.59M
Market Cap:116.07B
PE:12.66
High:47.74
Open:47.65
Low:47.34
Close:47.31
52wk High:60.12
52wk Low:44.62
Shares:2.44B
Float Shares:2.20B
Volume Ratio:0.60
T/O Rate:0.11%
Dividend:2.27
Dividend Rate:4.78%
EPS(TTM):3.76
EPS(LYR):3.76
ROE:6.66%
ROA:4.65%
PB:1.38
PE(LYR):12.66

Loading ...

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

MT Newswires Live
·
Yesterday

Regeneron, Sanofi announce FDA approval of Dupixent for AFRS

TIPRANKS
·
Feb 24

This Small-Cap Biotech Stock Is Soaring 35% on Excitement Over Its Prostate Cancer Drug -- Barrons.com

Dow Jones
·
Feb 24

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Feb 24

European Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live
·
Feb 24

Sector Update: Health Care

MT Newswires Live
·
Feb 20

Sanofi Sued by Texas Attorney General Over Alleged Provider 'Bribery'

MT Newswires Live
·
Feb 20

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ocular Therapeutix (OCUL) and Sanofi (SNY)

TIPRANKS
·
Feb 20

Press Release: Sanofi announces leadership evolution in Specialty Care Business Unit

Dow Jones
·
Feb 17

Teva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients

Benzinga_recent_news
·
Feb 17

Teva and Sanofi’s duvakitug Phase 2b data shows efficacy in colitis and Crohn’s

TIPRANKS
·
Feb 17

Looking for Dividends? Consider Europe. -- Barrons.com

Dow Jones
·
Feb 16

Income Investing: Looking for Dividends? Consider Europe. -- Barron's

Dow Jones
·
Feb 14

Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors

Benzinga
·
Feb 13

Sanofi's CEO Change Adds to Near-Term Uncertainty -- Market Talk

Dow Jones
·
Feb 13

Sanofi's New CEO Confronts Dual Hurdles: Sluggish R&D and Trump Era Uncertainties

Stock News
·
Feb 13

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Feb 13

Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'

Benzinga
·
Feb 12

Sanofi ‘decides not to renew’ mandate of CEO Paul Hudson

TIPRANKS
·
Feb 12

Sanofi says Belen Garijo to succeed Paul Hudson as CEO

TIPRANKS
·
Feb 12